IIBBA   05544
INSTITUTO DE INVESTIGACIONES BIOQUIMICAS DE BUENOS AIRES
Unidad Ejecutora - UE
artículos
Título:
Set-up of an infrared fast behavioral assay using zebrafish (Danio rerio) larvae, and its application in compound biotoxicity screening.
Autor/es:
BICHARA DARIO; CALCATERRA NORA; ARRANZ SILVIA; ARMAS PABLO; SIMONETTA SERGIO
Revista:
JOURNAL OF APPLIED TOXICOLOGY
Editorial:
JOHN WILEY & SONS LTD
Referencias:
Lugar: LOndres; Año: 2013 p. 1 - 8
ISSN:
0260-437X
Resumen:
:Zebrafish (Danio rerio) is increasingly employed for evaluating toxicity and drug discovery assays. Commonly experimental approaches for biotoxicity assessment are based on visual inspection or video recording. However, these techniques are limited for large-scale assays, as they demand ither a time-consuming detailed inspection of the animals or intensive computing resources in order to analyze a considerable amount of screenshots. Recently, we have developed a simple methodology for tracking the locomotor activity of small animals cultured in microtiter plates. In this work, we implemented this automatic methodology, based on infrared (IR) microbeam scattering, for measuring behavioral activity in zebrafish larvae. We determined the appropriate culture conditions, number of animals and stage of development to get robust results. Furthermore, we validated this methodology as a rapid test for evaluating toxicity. By measuring the effects of reference compounds on larvae activity, we were able to estimate the concentration that could cause a 50% decrease in activity events values (AEC50), showing a strong linear correlation (R2 = 0.91) with the LC50 values obtained with the standard DarT test. Thetoxicity order of the measured compounds was CuSO4 >2,4-dinitrophenol>3,4-dichloroaniline>SDS>sodium benzoate>EDTA>K2CrO4; regarding solvents, EtOHDMSO. In this study, we demonstrate that global swimming behavior could be a simple readout for toxicity, easy to scale-up in automated experiments. This approach is potentially applicable for fastecotoxicity assays and whole-organism high-throughput compound screening, reducing the time and money required to evaluate unknown samples and to identify leading pharmaceutical compounds.

